Delivery Order SPE2DB22D2214-SPE2DB24FS6RA
Award Date
9/11/24
Potential Completion Date
9/12/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.88 firm fixed price delivery order is for the procurement of Insulin Degludec Pen (U-200) 3ML, which is a specialty medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.88 firm-fixed-price delivery order is for the supply of insulin degludec pens (U-200, 3mL) to support military healthcare programs. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,045.19, is for the delivery of Insulin Degludec Pen (U-200) 3ML, a specialty medication used for diabetes management. The contract has a period of performance through October 29, 2024 and is structured as a Firm Fixed Price Delivery Order. The contracting vehicle for this award is an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,125.39, is for the delivery of insulin degludec pens (U-200, 3ML) to support military healthcare programs. The contract has an ultimate completion date of October 29, 2024 and is structured as a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.35, is for the supply of Insulin Degludec Pen (U-200) 3ML, a critical medical commodity for federal healthcare programs. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Insulin Degludec Pens (U-200) 3ML to the U.S. government. The $1,257.03 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of essential medical commodities,...
This federal contract award, valued at $1,071.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of INSULIN DEGLUDEC PEN (U-200) 3ML, a pharmaceutical product, with a period of performance through June 26, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,710.72 firm fixed price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military treatment facilities and federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Insulin Degludec Pen (U-200) 3ML, a critical diabetes medication. The total ceiling value of the contract is $11,425.47. This is a Firm Fixed Price Delivery Order contract with a completion date of August 14, 2024. The contract was not set aside for any specific business type. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-100, 3 mL). The contract is a delivery order with a firm fixed price of $1,288.93 and a completion date of May 13, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for...